(vianews) - merck and co inc (mrk.pa) is among this list of stock assets with the highest dividend rate and return on equity on the drug manufacturers—general industry.
| financial asset | price | forward dividend yield | return on equity |
|---|---|---|---|
| merck and co inc (mrk.pa) | €101.40 | 2.61% | 29.69% |
| virbac (virp.pa) | €270.00 | 0.48% | 15.51% |
several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.
1. merck and co inc (mrk.pa)
2.61% forward dividend yield and 29.69% return on equity
merck & co., inc. operates as a healthcare company worldwide. it operates through two segments, pharmaceutical and animal health. the pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. the animal health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. the company serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. it has collaborations with astrazeneca plc; bayer ag; eisai co., ltd.; ridgeback biotherapeutics lp; and gilead sciences, inc. to jointly develop and commercialize long-acting treatments in hiv. merck & co., inc. was founded in 1891 and is headquartered in rahway, new jersey.
earnings per share
as for profitability, merck and co inc has a trailing twelve months eps of €4.82.
pe ratio
merck and co inc has a trailing twelve months price to earnings ratio of 21.04. meaning, the purchaser of the share is investing €21.04 for every euro of annual earnings.
the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 29.69%.more news about merck and co inc.
2. virbac (virp.pa)
0.48% forward dividend yield and 15.51% return on equity
virbac sa manufactures and sells a range of products and services for companion animals and farm animals in france, europe, latin america, north america, asia, pacific, and africa and the middle east. the company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. it serves veterinarians, farmers, and pet owners. virbac sa was founded in 1968 and is headquartered in carros, france.
earnings per share
as for profitability, virbac has a trailing twelve months eps of €14.42.
pe ratio
virbac has a trailing twelve months price to earnings ratio of 18.72. meaning, the purchaser of the share is investing €18.72 for every euro of annual earnings.
the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 15.51%.volume
today's last reported volume for virbac is 692 which is 79.24% below its average volume of 3334.
revenue growth
year-on-year quarterly revenue growth grew by 12.2%, now sitting on 1.22b for the twelve trailing months.
more news about virbac.